Asset Purchase Agreement by and between Novartis Pharma AG, BioMarin Pharmaceutical Inc. And BioMarin Commercial Ltd.Asset Purchase Agreement • February 26th, 2018 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • New York
This Asset Purchase Agreement (this “Agreement”) is made and entered into as of November 21, 2017, by and among Novartis Pharma AG (“Buyer”), BioMarin Pharmaceutical Inc. (“BPI”), and BioMarin Commercial Ltd. (“Seller”). Buyer, BPI, and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
